Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DORIPENEM Cause Multiple organ dysfunction syndrome? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Multiple organ dysfunction syndrome have been filed in association with DORIPENEM. This represents 4.2% of all adverse event reports for DORIPENEM.

10
Reports of Multiple organ dysfunction syndrome with DORIPENEM
4.2%
of all DORIPENEM reports
9
Deaths
8
Hospitalizations

How Dangerous Is Multiple organ dysfunction syndrome From DORIPENEM?

Of the 10 reports, 9 (90.0%) resulted in death, 8 (80.0%) required hospitalization, and 3 (30.0%) were considered life-threatening.

Is Multiple organ dysfunction syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DORIPENEM. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does DORIPENEM Cause?

Hepatic function abnormal (28) Pyrexia (28) Diarrhoea (25) Sepsis (20) Drug ineffective (17) Liver disorder (16) Pneumonia (15) Drug resistance (12) Renal impairment (12) Febrile neutropenia (10)

What Other Drugs Cause Multiple organ dysfunction syndrome?

TACROLIMUS (1,847) CYCLOPHOSPHAMIDE (1,597) MYCOPHENOLATE MOFETIL (1,566) PREDNISONE (1,525) DEXAMETHASONE (1,355) METHOTREXATE (1,317) METHYLPREDNISOLONE (1,278) RITUXIMAB (1,188) PREDNISOLONE (1,154) CYCLOSPORINE (933)

Which DORIPENEM Alternatives Have Lower Multiple organ dysfunction syndrome Risk?

DORIPENEM vs DORNASE ALFA DORIPENEM vs DORZOLAMIDE DORIPENEM vs DORZOLAMIDE\TIMOLOL DORIPENEM vs DOSTARLIMAB DORIPENEM vs DOSTARLIMAB-GXLY

Related Pages

DORIPENEM Full Profile All Multiple organ dysfunction syndrome Reports All Drugs Causing Multiple organ dysfunction syndrome DORIPENEM Demographics